Physician profile
Allison B Readinger
NPI 1033256821
$6,397.42
in general payments reported to CMS, 2019-2025
39 companies · $763 in 2025
The $763 reported for 2025 was more than what a typical Dermatopathology (Dermatology) provider received nationally (typical 2025 total: $251).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,212 · 2020: $882 · 2021: $980 · 2022: $1,520 · 2023: $786 · 2024: $254 · 2025: $763.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,600 · Education: $203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,599.70 |
| Education | $203.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,229.70 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $743.98 | 2019-2025 | |
| Janssen Biotech, INC. | $636.32 | 2019-2025 | Tremfya, Stelara, Simponi Aria |
| Galderma Laboratories, L.P. | $403.92 | 2019-2025 | Nemluvio |
| Almirall LLC | $381.86 | 2019-2024 | Klisyri |
| Genzyme Corporation | $324.63 | 2020-2025 | |
| Lilly USA, LLC | $318.63 | 2019-2023 | Taltz, Olumiant |
| E.R. Squibb & Sons, L.L.C. | $254.45 | 2022-2025 | Sotyktu |
| Sun Pharmaceutical Industries INC. | $234.36 | 2019-2025 | Absorica Ld, Winlevi, Blu-U |
| Mayne Pharma Commercial LLC | $233.17 | 2019-2024 | |
| Regeneron Healthcare Solutions, INC. | $208.34 | 2022-2025 | Dupixent |
| Ucb, INC. | $180.86 | 2019-2022 | |
| Vyne Pharmaceuticals INC. | $132.05 | 2020-2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $116.20 | 2020-2024 | Cabtreo |
| Incyte Corporation | $94.03 | 2022-2025 | Opzelura |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Readinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.